InvestorsHub Logo

GinGinGin

06/28/21 8:20 PM

#39363 RE: GinGinGin #39362

The risk I see is the FDA. Other than that Multikine did well. Ar first glance it seems to be a replacement for the SOC. The only downside it did not cross the anticipated threshold. But it is still better than SOC and without side effects. Am I missing something?

Let's wait for the data.

GinGinGin

06/29/21 2:29 AM

#39377 RE: GinGinGin #39362

Correctin myself.

Radio + chemo results are missing. Group sizes too. Hopefully in the next few days.